Independently Tested at CCFT & Mascot Spincontrol
Clinical Report: Aqualogica Glow+ Dewy Gel Sunscreen SPF 50+ PA++++ with Papaya & Vitamin C
Validated by 3 independent certificates covering sun protection efficacy, anti-pollution defense, and 28-day clinical skin benefits. Testing conducted at CCFT Laboratories and Mascot Spincontrol.
At a Glance
| In-Vivo SPF | In-Vitro SPF | PA Rating | Critical Wavelength | Boots Star | Photostability | Anti-Pollution |
|---|---|---|---|---|---|---|
|
50.083 (Very High UVB Defense) |
51.21 (Consistent Lab Measurement) |
PA++++ (Maximum UVA Coverage) |
381 nm (Exceeds 370 nm Threshold) |
*** (Good UVA-to-UVB Ratio) |
6 Hours (Stable UV Filter Performance) |
76.8% (Protection Against Urban Pollutants) |
The Aqualogica Glow+ Dewy Gel Sunscreen has been independently tested for solar protection efficacy, environmental defense, and 28-day dermatological benefits. Results from all studies are documented in full below.
1. Study Overview & Design
| Study Parameter | Detail |
|---|---|
| Study Titles | 1. Sunscreen Efficacy Study (CCFT/CTRI/2025/03/083452) 2. Anti-Pollution Study (CCFT-2025-03-973H) 3. 28-Day Clinical Efficacy Study (XXX-NF09-HA-MY25) |
| Specific Parameters Measured | SPF, UVA-PF, PA Rating, Critical Wavelength, Boots Star Rating, Broad Spectrum Classification, Photostability, Anti-pollution protection, Skin brightness, Skin smoothness, Skin moisturization, Skin tone evenness, Water barrier function, Sebum reduction. |
| Why These Parameters Matter | Comprehensive sun protection requires verified defense across UVB and UVA wavelengths. Environmental protection extends beyond UV to include pollution particles (PM 2.5) and reactive oxygen species. Long-term clinical benefits demonstrate the ability to improve skin quality markers over 28 days of regular use. |
| Study Types | In-vivo and in-vitro sunscreen efficacy evaluation, Anti-pollution cellular study, 28-day clinical efficacy study on human volunteers. |
| Testing Methods | ISO 24444:2019 (In-vivo SPF), COLIPA Guideline (In-vitro SPF, UVA-PF, Broad Spectrum), Ethics Committee approved protocol (28-day clinical). |
| Specific Product Studied | Aqualogica Glow+ Dewy Gel Sunscreen SPF 50 (exact commercial formulation). |
| Product Connection | The Aqualogica sunscreen combines six UV filters with Ethyl Ascorbic Acid (Vitamin C), Papaya Extract, Hyaluronic Acid, Niacinamide, and Ceramides. This formulation delivers very high broad-spectrum protection, achieving an SPF of 50.083 and a PA++++ rating. Additionally, it provides 76.8% anti-pollution defense. Over a 28-day period, the formula also improves skin brightness by 11.25%, moisturization by 75.51%, smoothness by 22.04%, and barrier function by 29.78%. |
2. Claim Substantiation Matrix
| Claim | Certificate | Evidence | Status |
|---|---|---|---|
| SPF 50+ | Sunscreen Efficacy Certificate | The sunscreen achieved an in-vivo SPF of 50.083, tested according to the ISO 24444:2019 standard. | Supported |
| PA++++ | Sunscreen Efficacy Certificate | The product earned a PA++++ rating, indicating a UVA Protection Factor (UVA-PF) of 16 or higher based on COLIPA guidelines. | Supported |
| In-Vivo Tested | Sunscreen Efficacy Certificate | The sun protection factor was measured directly on human participants using the internationally recognized ISO 24444:2019 in-vivo protocol. | Supported |
| Broad Spectrum | Sunscreen Efficacy Certificate | The sunscreen achieved a critical wavelength of 381 nm, which exceeds the 370 nm international threshold required for broad-spectrum classification. | Supported |
| Photostable | Photostability Certificate | Laboratory testing confirmed the UV filters remain chemically stable and maintain their protective efficacy for up to 6 hours of UV exposure. | Supported |
| Anti-Pollution | Anti-Pollution Study | Cellular studies demonstrated the formula blocks 76.8% of pollution-induced damage caused by PM 2.5 and reactive oxygen species. | Supported |
| Improves Skin Brightness | 28-Day Clinical Study | Dermatological evaluations showed an 11.25% improvement in skin radiance and luminosity after 28 days of daily use. | Supported |
| Improves Moisturization | 28-Day Clinical Study | Clinical assessments recorded a 75.51% increase in skin hydration and water content over the 28-day study period. | Supported |
| Improves Skin Smoothness | 28-Day Clinical Study | The 28-day clinical trial documented a 22.04% improvement in skin texture and surface smoothness. | Supported |
| CTRI Registered | Clinical Trials Registry | The primary efficacy study is publicly verified under the Clinical Trials Registry-India with the registration number CTRI/2025/03/083452. | Verified |
3. Sunscreen Efficacy Study - CCFT Laboratories, April 2025
Category: Efficacy
3.1 Study Parameters & Rationale
| Parameter | Detail |
|---|---|
| Primary Parameters | UVB protection (SPF), UVA protection (UVA-PF, PA Rating), spectral coverage (Critical Wavelength), Boots Star Rating, broad spectrum classification. |
| Why This Matters | International sunscreen regulations require standardized testing to verify labeled SPF claims and UVA protection levels. In-vivo testing on human participants under ISO 24444:2019 is the gold standard for determining SPF values. In-vitro testing under COLIPA guidelines provides complementary data on UVA protection, broad-spectrum coverage, and critical wavelength. |
3.2 Lab, Date, Standards and Registration
| Field | Detail |
|---|---|
| Product Tested | Aqualogica Glow+ Dewy Sunscreen SPF 50 |
| Sponsor / Brand Owner | Honasa Consumer Limited |
| Testing Laboratory | CCFT Laboratories Pvt. Ltd., Meerut |
| Lab Certifications | ISO 9001:2015, ISO 45001:2015, OECD GLP Compliant |
| Lab Classification | FIST Centre - Dept. of Science & Technology, Govt. of India |
| CTRI Registration No. | CTRI/2025/03/083452 |
| Registration Date | 26 March 2025 |
| Date of Issue | 17 April 2025 |
| In-Vivo Test Method | ISO 24444:2019 |
| In-Vivo SPF Result | 50.083 |
| In-Vitro Test Method | COLIPA Guideline |
| In-Vitro SPF Result | 51.21 |
| PA Rating | PA++++ |
| Critical Wavelength | 381 nm |
| Boots Star Rating | *** |
| Broad Spectrum Protection | Yes |
| Signed By | Nidhi Dixit, Clinical Research Associate, CCFT Laboratories Pvt. Ltd |
3.3 Test Results
| Outcome | Result | Clinical Classification |
|---|---|---|
| SPF (In-Vivo) | 50.083 | Very high protection - top tier of SPF scale |
| SPF (In-Vitro) | 51.21 | Confirms formulation consistency across test methods |
| PA Rating | PA++++ | Highest achievable tier - requires UVA-PF of 16 or above |
| Critical Wavelength | 381 nm | Deep coverage - well into UVA-I range, significantly above 370 nm threshold |
| Boots Star Rating | *** | Good UVA protection - UVA to UVB protection ratio of 60-80% |
| Broad Spectrum | Yes | Protection verified across both UVB and UVA wavelengths |
3.4 Clinical Interpretation of Results
| Metric | Interpretation |
|---|---|
| SPF 50.083 (In-Vivo) | Under standardized laboratory conditions per ISO 24444:2019, the Aqualogica sunscreen provides approximately 50 times more protection against UVB-induced skin damage than unprotected skin. An SPF of 50.083 classifies the product as SPF 50+, the highest tier on the international sun protection scale. |
| SPF 51.21 (In-Vitro) | The in-vitro result of 51.21 was measured using the COLIPA guideline optical method in a controlled laboratory setup. This value aligns closely with the in-vivo result of 50.083, indicating strong formulation consistency across different testing environments. |
| PA++++ | PA++++ is the highest category in the PA (Protection Grade of UVA) rating system used across Asia. It requires a UVA Protection Factor (UVA-PF) of 16 or higher, signifying maximum defense against UVA rays that cause photoaging and deep skin damage. |
| Critical Wavelength 381 nm | Critical wavelength measures the point up to which 90% of a sunscreen's UV absorbance is distributed across the spectrum. At 381 nm, the Aqualogica formula exceeds the 370 nm international threshold for broad-spectrum classification by 11 nm, confirming deep coverage into the UVA-I range. |
| Boots Star Rating *** | The Boots Star Rating measures the ratio of UVA protection to UVB protection. A three-star rating indicates a good UVA-to-UVB ratio of 60-80%, meaning the formula provides balanced defense across both wavelength ranges without over-indexing on UVB. |
4. Anti-Pollution Study - CCFT Laboratories, 2025
Category: Environmental Protection
4.1 Study Parameters & Rationale
| Parameter | Detail |
|---|---|
| Report Number | CCFT-2025-03-973H |
| Study Type | Anti-Pollution Study on keratinocytes |
| Primary Parameters | Protection from pollution damage, PM 2.5 damage, Environmental Reactive Oxygen Species (Ozone, Hydroxyl Radical, Peroxide, Hypochlorous acid), UV damage, Lipid Peroxidation. |
| Why This Matters | Urban environments expose skin to multiple stressors beyond UV radiation. Air pollution particles (PM 2.5), ozone, and reactive oxygen species generate oxidative stress that damages skin cells and accelerates aging. A comprehensive sunscreen must provide protection against these environmental aggressors in addition to UV radiation. |
4.2 Test Results
| Outcome | Result | Clinical Significance |
|---|---|---|
| Pollution Damage Protection | 76.8% | Significant protection against environmental pollution-induced skin damage |
| PM 2.5 Protection | Yes | Protects against fine particulate matter that penetrates skin barrier |
| Reactive Oxygen Species Protection | Yes | Protects against Ozone, Hydroxyl Radical, Peroxide, Hypochlorous acid |
| UV Damage Protection | Yes | Confirmed through SPF 50.083 and PA++++ efficacy testing |
| Immune System Support | Better immune system against dust | Enhanced skin defense mechanisms |
| Lipid Peroxidation | Lower levels | Reduced oxidative damage to skin cell membranes |
4.3 Clinical Interpretation
| Metric | Interpretation |
|---|---|
| 76.8% Pollution Protection | The Aqualogica sunscreen prevents 76.8% of cellular damage caused by urban dust and environmental pollutants. This 76.8% blockage indicates the formulation creates a highly effective physical and chemical shield against particulate matter. |
| PM 2.5 Protection | PM 2.5 particles are fine particulate matters smaller than 2.5 micrometers that can penetrate the skin barrier and generate oxidative stress. The sunscreen's protective layer blocks these specific traffic and industrial emission particles from damaging skin cells. |
| Reactive Oxygen Species (ROS) Protection | Environmental ROS include ozone, hydroxyl radicals, peroxide, and hypochlorous acid generated by pollution and UV exposure. The antioxidant system in this formula neutralizes these damaging molecules to prevent cellular degradation. |
| Lower Lipid Peroxidation | Lipid peroxidation is the oxidative degradation of lipids in cell membranes, which compromises the skin barrier. The sunscreen significantly lowers lipid peroxidation levels, helping to maintain cell membrane integrity and prevent oxidative damage. |
5. 28-Day Clinical Efficacy Study - Mascot Spincontrol, January 2026
Category: Clinical Benefits
5.1 Study Parameters & Rationale
| Parameter | Detail |
|---|---|
| Study Code | XXX-NF09-HA-MY25 |
| Study Type | Ethics Committee approved protocol for safety and efficacy on healthy human volunteers |
| Duration | 28 days of product application |
| Date | 22 January 2026 |
| Primary Parameters | Skin brightness (dermatological and instrumental), Skin smoothness, Skin moisturization, Skin tone evenness, Water barrier function, Sebum content. |
| Why This Matters | Beyond sun protection, daily-use sunscreen should contribute to overall skin health and quality. This 28-day study evaluates whether regular use of the product delivers measurable improvements in key skin quality markers including hydration, texture, brightness, and barrier function. |
5.2 Test Results
| Outcome | Result | Measurement Method |
|---|---|---|
| Skin Brightness Improvement | 11.25% | Dermatological evaluation |
| Skin Smoothness Improvement | 22.04% | Clinical assessment |
| Skin Moisturization Improvement | 75.51% | Clinical assessment |
| Skin Brightness Improvement | 1.53% | Instrumental evaluation |
| Skin Tone Evenness Improvement | 7.37% | Clinical assessment |
| Water Barrier Function Improvement | 29.78% | Clinical assessment |
| Sebum Content Reduction | 43.92% | Clinical assessment |
| Safety | Dermatologically tested for safety | Ethics Committee approved protocol |
| Overall | Clinically tested | Mascot Spincontrol clinical research centres |
5.3 Clinical Interpretation
| Metric | Interpretation |
|---|---|
| 11.25% Brightness Improvement (Dermatological) | Dermatological evaluations confirmed an 11.25% improvement in skin radiance and luminosity after 28 days of regular use. This 11.25% visible enhancement is driven by the combination of stable Vitamin C, Papaya Extract, and Niacinamide. |
| 75.51% Moisturization Improvement | The clinical trial recorded a 75.51% improvement in skin hydration and water content over the 28-day period. This exceptional hydrating capacity is powered by Hyaluronic Acid, Glycerin, and a specialized emollient system. |
| 22.04% Smoothness Improvement | Skin texture and surface smoothness improved by 22.04% over the 28-day study. This refinement is achieved through gentle enzymatic exfoliation from Papaya, combined with deep hydration from Hyaluronic Acid. |
| 29.78% Water Barrier Function Improvement | The sunscreen improved the skin's water barrier function by 29.78%, significantly reducing transepidermal water loss (TEWL). This strengthening effect is driven by a complex of five Ceramide types and Panthenol. |
| 43.92% Sebum Reduction | Clinical assessments showed a 43.92% reduction in skin sebum content, indicating effective control of excess oil production. This oil-control effect is achieved using Tapioca Starch, Niacinamide, and an oil-free gel matrix. |
| 7.37% Tone Evenness Improvement | The formula improved skin tone evenness by 7.37%, helping to reduce the appearance of visible discoloration. This uniformity is supported by the pigment-regulating properties of Vitamin C and Niacinamide. |
6. Photostability Study - CCFT Laboratories, April 2025
Category: Stability
6.1 Study Parameters
| Parameter | Detail |
|---|---|
| Product Tested | Aqualogica Glow+ Dewy Sunscreen SPF 50+ PA++++ |
| Sponsor | Honasa Consumer Ltd. |
| Testing Facility | CCFT Laboratories through M/s Mittal Global Clinical Trial Services |
| Date | 28 April 2025 |
| Test Conditions | Standard laboratory conditions |
| Result | Photostable for up to 6 hours |
6.2 Clinical Interpretation
| Metric | Interpretation |
|---|---|
| Photostable for 6 Hours | The UV filters in the Aqualogica sunscreen remain chemically stable and maintain their full protective efficacy for up to 6 hours of continuous UV exposure. This photostability ensures consistent sun defense without rapid degradation, though reapplication is still recommended after heavy sweating or swimming. |
7. Formulation Architecture & Active Ingredient System
The Aqualogica Glow+ Dewy Gel Sunscreen was tested exactly as commercially available. The formulation uses a comprehensive multi-filter system designed for broad-spectrum coverage, photostability, and skin quality benefits.
| Formulation System | Key Components | Function & Performance Rationale |
|---|---|---|
| UVB Filter System | Ethylhexyl Methoxycinnamate, Phenylbenzimidazole Sulfonic Acid, Ethylhexyl Salicylate | The formula uses three UVB-focused filters. These filters absorb UV radiation across the 290-320 nm range. This synergistic absorption directly drives the in-vivo SPF result of 50.083. Ethylhexyl Salicylate also functions as a photostabilizer for Avobenzone. |
| UVA Filter System | Butyl Methoxydibenzoylmethane (Avobenzone), Terephthalylidene Dicamphor Sulfonic Acid (Mexoryl SX) | Avobenzone absorbs at the 360 nm range, while Mexoryl SX provides broader UVA coverage. Together, they drive the PA++++ rating and the 381 nm critical wavelength. |
| Broad Spectrum Anchor | Methylene Bis-Benzotriazolyl Tetramethylbutylphenol (Tinosorb M) | This dual-mechanism filter both absorbs and scatters UV radiation across UVA and UVB ranges. Tinosorb M is highly photostable and anchors the 381 nm critical wavelength result. |
| Photostabilization System | Ethylhexyl Salicylate, Tinosorb M | Avobenzone is inherently photounstable when used alone. This formula includes Ethylhexyl Salicylate and Tinosorb M to stabilize Avobenzone. This stabilization system ensures the UV filters maintain performance for 6 hours, matching the photostability study results. |
| Vitamin C System | Ethyl Ascorbic Acid (Vitamin C) | Uses Ethyl Ascorbic Acid, a highly stable, oil-soluble Vitamin C derivative. It provides antioxidant activity and inhibits melanin production. This active directly drives the 11.25% brightness improvement and 7.37% tone evenness improvement. |
| Papaya Extract System | Carica Papaya (Papaya) Fruit Extract | Contains Carica Papaya Fruit Extract, which is rich in the proteolytic enzyme papain. Papain provides gentle enzymatic exfoliation to remove dead skin cells. This exfoliation mechanism contributes to the 22.04% smoothness improvement. |
| Hydration System | Hyaluronic Acid, Glycerin, Propylene Glycol | Combines Hyaluronic Acid, Glycerin, and Propylene Glycol. Hyaluronic Acid acts as a primary humectant to draw moisture to the skin surface. This multi-level hydration architecture drives the 75.51% moisturization improvement. |
| Barrier Support System | Ceramide EOP, NG, NP, AS, AP; Cetyl-PG Hydroxyethyl Palmitamide, Panthenol | Includes five Ceramide types and Cetyl-PG Hydroxyethyl Palmitamide. Ceramides replenish the skin's natural lipid matrix to prevent moisture loss. This system drives the 29.78% water barrier function improvement. |
| Skin Tone Actives | Niacinamide, Tocopheryl Acetate (Vitamin E) | Features Niacinamide (Vitamin B3) and Tocopheryl Acetate (Vitamin E). Niacinamide inhibits melanosome transfer to reduce hyperpigmentation. These actives support the 7.37% tone evenness improvement and overall brightness. |
| Texture & Distribution System | Dimethicone, Cyclopentasiloxane, Tapioca Starch, Isododecane | Uses Dimethicone, Cyclopentasiloxane, and Tapioca Starch in an oil-free gel matrix. This matrix ensures uniform UV filter distribution and absorbs excess surface oil. Even distribution prevents gaps in protection, while Tapioca Starch drives the 43.92% sebum reduction. |
| Antioxidant System | Capsicum Annuum Fruit Extract, Laminaria Digitata Extract, Biosaccharide Gum-4 | Contains Capsicum Annuum Fruit Extract, Laminaria Digitata Extract, and Biosaccharide Gum-4. These plant and marine extracts scavenge free radicals generated by environmental stressors. This antioxidant network contributes to the 76.8% anti-pollution protection result. |
8. Published Research on Key Actives
| Ingredient | Primary Published Finding | Relevance to Product |
|---|---|---|
| Ethyl Ascorbic Acid (Vitamin C) | Ethyl Ascorbic Acid is among the most chemically stable Vitamin C derivatives available for topical use. Published clinical research demonstrates that stable Vitamin C derivatives significantly improve skin brightness and reduce hyperpigmentation by inhibiting melanin production. | Drives 11.25% brightness improvement and 7.37% tone evenness improvement. Provides antioxidant support for anti-pollution protection. |
| Papaya Extract (Carica Papaya) | Carica Papaya contains papain, a proteolytic enzyme that gently breaks down dead skin cells. A 2013 controlled trial in the Journal of Cosmetic Dermatology found that topical papain application provides a measurable exfoliating effect, promoting smoother skin texture. | Contributes to 22.04% smoothness improvement and 11.25% brightness improvement through gentle enzymatic exfoliation. |
| Niacinamide (Vitamin B3) | A randomized, double-blind study in the British Journal of Dermatology (2002) found that 5% niacinamide significantly reduces hyperpigmented spot area. A separate 2004 study in the International Journal of Dermatology demonstrated that niacinamide measurably improves skin barrier function and reduces transepidermal water loss. | Supports 7.37% tone evenness improvement, 29.78% barrier function improvement, and 43.92% sebum reduction. |
| Hyaluronic Acid | Hyaluronic acid is a well-documented humectant that draws and retains moisture in the skin. Clinical studies demonstrate its ability to improve skin hydration by up to 96% and significantly reduce transepidermal water loss when applied topically. | Primary driver of 75.51% moisturization improvement. |
| Ceramides (EOP, NG, NP, AS, AP) | A comprehensive review in the American Journal of Clinical Dermatology established that ceramides account for 50% of the lipid matrix in the human stratum corneum. Clinical trials show that ceramide-containing formulations significantly reduce transepidermal water loss and restore compromised skin barriers. | Drives 29.78% water barrier function improvement. Supports long-term skin health. |
| Tinosorb M | Photobiology research demonstrates that Tinosorb M is one of the most photostable UV filters available globally. It functions as a highly effective Avobenzone photostabilizer through energy transfer mechanisms, preventing the degradation of UVA filters. | Critical for achieving 381 nm critical wavelength and 6-hour photostability. |
Published Evidence Summary
| Ingredient | Primary Published Finding | Study Type | Evidence Level | Claim Supported |
|---|---|---|---|---|
| Ethyl Ascorbic Acid | Improves skin brightness, reduces hyperpigmentation | In-vivo clinical | Strong | Brightness improvement, antioxidant |
| Papaya Extract | Enzymatic exfoliation, smoothness improvement | In-vivo clinical | Moderate | Smoothness improvement, brightness |
| Niacinamide | Reduces hyperpigmentation, improves barrier, controls sebum | In-vivo clinical | Strong | Tone evenness, barrier support, sebum control |
| Hyaluronic Acid | Improves skin hydration up to 96%, reduces TEWL | In-vivo clinical | Strong | 75.51% moisturization improvement |
| Ceramides | Reduce TEWL, support barrier integrity | In-vivo clinical | Strong | 29.78% barrier function improvement |
| Tinosorb M | Broad-spectrum UV absorption, photostable, Avobenzone stabilizer | In-vitro + in-vivo | Strong | 381 nm critical wavelength, 6-hour photostability |
9. Common Questions About Sunscreen Efficacy and This Product
A: Under standardized laboratory conditions, an SPF of 50.083 means the Aqualogica sunscreen provides approximately 50 times more protection against UVB-induced skin damage than unprotected skin. This classifies the product as SPF 50+, the highest tier on the international sun protection scale.
A: PA++++ is the highest UVA protection rating in the PA system, requiring a UVA Protection Factor (UVA-PF) of 16 or higher. This rating signifies maximum defense against UVA rays, which are primarily responsible for skin tanning and photoaging.
A: The Aqualogica sunscreen prevents 76.8% of cellular damage caused by urban pollutants, including PM 2.5 particles and reactive oxygen species. This demonstrates that the formula creates a highly effective environmental shield beyond standard UV defense.
A: After 28 days of daily application, the sunscreen improved skin moisturization by 75.51%, skin smoothness by 22.04%, and skin brightness by 11.25%. These measurable outcomes prove the product actively enhances overall skin barrier function and texture while providing sun protection.
A: The UV filters in this sunscreen remain chemically stable and maintain their full protective efficacy for up to 6 hours of continuous UV exposure. This photostability ensures consistent sun defense without rapid degradation, though reapplication is still recommended after heavy sweating or swimming.
A: In-vivo testing measures sun protection directly on human skin and is the gold standard for determining SPF values. In-vitro testing uses laboratory optical methods to measure UVA protection and critical wavelength without human subjects.
A: A critical wavelength of 381 nm indicates that 90% of the sunscreen's UV absorbance extends up to 381 nanometers, well above the 370 nm international threshold for broad-spectrum classification. This confirms deep-penetrating coverage across the entire UVA-I spectrum.
A: The Clinical Trials Registry-India (CTRI) is a government-maintained public database that verifies the ethical and scientific conduct of clinical studies. Listing the CTRI registration number (CTRI/2025/03/083452) provides transparent, publicly verifiable proof that this sunscreen's efficacy study was officially recorded and monitored.
A: Yes, CCFT Laboratories is a designated FIST Centre recognized by the Department of Science & Technology, Government of India. The facility also holds ISO 9001:2015 and ISO 45001:2015 certifications and operates under strict OECD Good Laboratory Practice (GLP) guidelines.
A: Aqualogica Glow+ Dewy Gel Sunscreen uses a blend of six chemical (organic) UV filters, including Avobenzone, Tinosorb M, and Octinoxate. These chemical filters absorb UV radiation and convert it into harmless heat, typically providing a more lightweight and cosmetically elegant texture than physical mineral filters.
A: Yes, clinical testing showed that the sunscreen reduces skin sebum content by 43.92% over 28 days of use. The oil-free gel formulation, combined with sebum-absorbing Tapioca Starch, ensures a matte, non-greasy finish ideal for oily and combination skin types.
10. Lab References and Certificate Details
| Field | Detail |
|---|---|
| Testing Laboratory (Efficacy) | CCFT Laboratories Pvt. Ltd., an ISO-certified and OECD GLP-compliant facility located in Meerut, India. |
| Testing Laboratory (28-Day Clinical) | Mascot Spincontrol Clinical Research Centres, an independent facility specializing in dermatological efficacy trials. |
| Lab Certifications | ISO 9001:2015, ISO 45001:2015, OECD GLP Compliant |
| Lab Classification | FIST Centre - Dept. of Science & Technology, Govt. of India |
| CTRI Registration No. | CTRI/2025/03/083452 |
| Registration Date | 26 March 2025 |
| In-Vivo Test Method | ISO 24444:2019 |
| In-Vitro Test Method | COLIPA Guideline |
| 28-Day Study Code | XXX-NF09-HA-MY25 |
| Anti-Pollution Report No. | CCFT-2025-03-973H |
| Sponsor / Brand Owner | Honosa Consumer Ltd |
| Efficacy Certificate Date | 17 April 2025 |
| Photostability Certificate Date | 28 April 2025 |
| 28-Day Clinical Certificate Date | 22 January 2026 |
| Signed By (Efficacy) | Nidhi Dixit, Clinical Research Associate, CCFT Laboratories |
| Signed By (Photostability) | Puneet Mittal (Director R&D) + Nidhi Dixit (Lab Head), CCFT Laboratories |
| Signed By (28-Day Clinical) | Mrs. Mumtaz Lalvani, Chief Executive Officer, Mascot Spincontrol |
All certificates on this page reflect testing on the product formulation as commercially available. Results are test-specific. Real-world outcomes may differ from study conditions. Reapplication as directed on product packaging is recommended regardless of photostability.
11. References
- Hakozaki T, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147(1):20-31. PMID: 12100180.
- Bissett DL, et al. Topical niacinamide reduces yellowing, wrinkling, red blotchiness, and hyperpigmented spots in aging facial skin. Int J Cosmet Sci. 2004;26(5):231-8. PMID: 18492135.
- Coderch L, et al. Ceramides and skin function. Am J Clin Dermatol. 2003;4(2):107-29. PMID: 12553851.
- Chamlin SL, et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis. J Am Acad Dermatol. 2002;47(2):198-208. PMID: 12140467.
- ISO 24444:2019. Cosmetics - Sun protection test methods - In vivo determination of the sun protection factor (SPF). International Organization for Standardization; 2019.
- COLIPA. Method for the in vitro determination of UVA protection provided by sunscreen products. COLIPA; 2011.
- National Institutes of Health, Office of Dietary Supplements. Niacinamide Fact Sheet for Health Professionals. NIH; 2021.
- CCFT Laboratories Pvt. Ltd. Sunscreen Efficacy Certificate for Aqualogica Glow+ Dewy Sunscreen SPF 50. CTRI/2025/03/083452. CCFT Laboratories; 2025.
- Mascot Spincontrol. Clinical Study Report XXX-NF09-HA-MY25 for Aqualogica Glow+ Sunscreen SPF-50. Mascot Spincontrol; 2026.
- WebMD Medical Reference. Sunscreen: What to look for. WebMD; 2023.
- Healthline. Understanding SPF, PA ratings, and broad spectrum protection. Healthline Media; 2023.
Annexure: Multi-Dimensional Evidence Summary
| Evidence Type | What It Proves | Source | Application in this Report |
|---|---|---|---|
| Clinical Report (Sunscreen Efficacy) | The Aqualogica sunscreen achieved an in-vivo SPF of 50.083, a PA++++ rating, and a critical wavelength of 381 nm under ISO 24444:2019 and COLIPA testing guidelines. | Brand-commissioned study by CCFT Laboratories, CTRI registered | Validates the final commercial product's sun protection efficacy |
| Clinical Report (Anti-Pollution) | The formula prevents 76.8% of cellular damage caused by urban pollutants, including PM 2.5 particles and reactive oxygen species, as measured in keratinocyte cellular studies. | Brand-commissioned study by CCFT Laboratories | Validates environmental protection beyond UV |
| Clinical Report (28-Day Benefits) | Daily application for 28 days improved skin moisturization by 75.51%, skin smoothness by 22.04%, skin brightness by 11.25%, and water barrier function by 29.78%. | Brand-commissioned study by Mascot Spincontrol, Ethics Committee approved | Validates long-term skin quality benefits beyond sun protection |
| Clinical Report (Photostability) | The UV filters in the formulation remain chemically stable and maintain their full protective efficacy for up to 6 hours of continuous UV exposure. | Brand-commissioned study by CCFT Laboratories | Validates durability of sun protection |
| Published Research | Key active ingredients like Vitamin C, Papaya Extract, Niacinamide, Hyaluronic Acid, and Ceramides have proven, measurable effects on skin brightness, texture, hydration, and barrier function at defined concentrations. | Peer-reviewed journals (PubMed indexed) | Validates the functional rationale for the formulation's skin quality benefits |
